Drug Discovery World
JANUARY 4, 2023
China is expected to record the highest diagnosed prevalence of non-alcoholic fatty liver disease (NAFLD) in 2029, representing 44% of cases within the 16 major pharmaceutical markets (16MM). According to GlobalData’s [.]. To read this content in full, you need to login.
Drug Discovery World
MAY 15, 2024
million diagnosed cases of diabetic retinopathy in the nine major pharmaceutical markets, expected to grow to >17.7 million by 2029, according to GlobalData. Beech has over 25 years of biotech and pharmaceutical industry experience. In 2019 there were >14.2 Pete Adamson is CSO at Breye Therapeutics.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Alta Sciences
MARCH 8, 2024
Inside the Altascientist: Considerations for Safe and Compliant HPAPI Manufacturing pmjackson Fri, 03/08/2024 - 19:35 In recent years, advancements in oncological research have fueled a surge in demand for highly potent active pharmaceutical ingredients ( HPAPIs ). billion by 2029.
Drug Discovery World
JANUARY 9, 2024
Thirteen new-to-market therapeutics and drugs poised to launch in 2024 will achieve ‘blockbuster’ status by 2029 or deliver game-changing benefits to patients. If approved , it would be the first in class as well as the first novel mechanism that has become available for maintenance COPD treatment in more than 10 years.
Policy Prescription
MARCH 26, 2021
Would you vote for legislation to lower drug prices that would lead to a five percent reduction in pharmaceutical innovation — yet simultaneously create a health system in which all Americans could afford the prescription drugs they need? The savings to the government would be about $345 billion between 2023-2029 because of lower prices.
Vial
MARCH 1, 2024
Introduction Contract research organizations (CROs) are essential in pharmaceutical research and development (R&D). billion by 2029. By geographical region, the global CRO services market in 2023 was dominated by North America. As a result, the global CRO market is estimated to grow at a compound annual growth rate (CAGR) of 9.6%
Drug Discovery World
OCTOBER 4, 2022
As one of the exciting fields in the pharmaceutical industry, it’s no surprise that Drug Discovery 2022 will feature sessions on developments in CAR-T and the technologies helping researchers in this field. . The psychedelics medicine market is rising in value, with Data Bridge Market Research predicting it will reach $8 billion by 2029.
Expert insights. Personalized for you.
130 
Let's personalize your content